Heart failure is the end-stage condition of a number of cardiac disorders. Cardiac hypertrophy is the main? risk factor for heart failure, peroxisome proliferator activated receptors (PPARalpha, -delta and -gamma),? plays important roles in regulating lipid metabolic genes. Our laboratory has previously based on studies on? a unique cardiomyocyte-restricted PPARdelta knockout (CR-PPARdelta-/-) mouse line demonstrated that the? PPARdelta subtype as a determinant of basal myocardial fatty acid oxidation (FAO). These studies? established that PPARdelta is an essential determinant of myocardial FAO. Recent studies suggest that? synthetic ligands of PPARdelta exert anti-hypertrophic effects on cultured cardiomyocytes. Our preliminary? studies indicated that PPARdelta expression is downregulated in hypertrophied ventricles. In addition,? PPARdelta activation and overexpression in cultured cardiomyocytes suppressed inflammatory response in? cultured cardiomyocytes. However, it remains unclear whether PPARdelta exerts anti-hypertrophic effects in? response to hypertrophic stimuli. In this proposed project we will utilize the cultured cardiomyocyte system? and the conditional cardiomyocyte-specific mouse models to test the central hypothesis that PPARdelta is a? key regulator of cardiac growth in response to hypertrophic stimuli via crosstalks with other transcriptional? pathways that are involved in cardiac growth. We will specifically study the following aims: to determine if? PPARdelta interferes with other signaling pathways to influence cell growth of cultured cardiomyocytes in? vitro; to determine the role of PPARdelta in the development of cardiac hypertrophy in vivo; and to determine? the role of PPARdelta in the progression from compensated remodeling to heart failure. Results from these? studies should provide in vivo evidence on a potential role of PPARdelta as a negative regulator of cardiac? hypertrophic growth and progression to heart failure. Further understanding the molecular mechanisms? underlying the development of cardiac hypertrophy and heart failure should help to provide novel therapeutic? targets to treat heart failure.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Minority Biomedical Research Support - MBRS (S06)
Project #
Application #
Study Section
Minority Programs Review Committee (MPRC)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Morehouse School of Medicine
United States
Zip Code
Wilson, Nana O; Solomon, Wesley; Anderson, Leonard et al. (2013) Pharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malaria. PLoS One 8:e60898
Igietseme, Joseph U; Omosun, Yusuf; Partin, James et al. (2013) Prevention of Chlamydia-induced infertility by inhibition of local caspase activity. J Infect Dis 207:1095-104
Wilson, Nana; Driss, Adel; Solomon, Wesley et al. (2013) CXCL10 gene promoter polymorphism -1447A>G correlates with plasma CXCL10 levels and is associated with male susceptibility to cerebral malaria. PLoS One 8:e81329
Kim, Teayoun; Zhelyabovska, Olga; Liu, Jian et al. (2013) Generation of an inducible, cardiomyocyte-specific transgenic mouse model with PPAR ?/? overexpression. Methods Mol Biol 952:57-65
Shelton, Martin N; Huang, Ming-Bo; Ali, Syed A et al. (2012) Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release. J Virol 86:406-19
Campbell, Patrick E; Isayev, Olexandr; Ali, Syed A et al. (2012) Validation of a novel secretion modification region (SMR) of HIV-1 Nef using cohort sequence analysis and molecular modeling. J Mol Model 18:4603-13
Liu, Mingli; Amodu, Audu S; Pitts, Sidney et al. (2012) Heme mediated STAT3 activation in severe malaria. PLoS One 7:e34280
Wilson, Nana O; Ceesay, Fatou K; Hibbert, Jacqueline M et al. (2012) Pregnancy outcomes among patients with sickle cell disease at Korle-Bu Teaching Hospital, Accra, Ghana: retrospective cohort study. Am J Trop Med Hyg 86:936-42
Wilson, Nana O; Ceesay, Fatou K; Obed, Samuel A et al. (2011) Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women. Am J Trop Med Hyg 85:12-21
Lucchi, Naomi W; Jain, Vidhan; Wilson, Nana O et al. (2011) Potential serological biomarkers of cerebral malaria. Dis Markers 31:327-35

Showing the most recent 10 out of 122 publications